3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
9
Esophageal Squamous Cell Carcinoma
5
Neoplasm Metastasis
4
Carcinoma, Hepatocellular
4
Advanced Solid Tumors
4
Recurrence
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Solid Tumors
1
Sarcoma
1
Neuroendocrine Tumors
1
Nasopharyngeal Neoplasms
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Locally Advanced or Metastatic Urothelial Bladder Cancer
1
Interventions
Cisplatin
9
Cetuximab
6
Radiotherapy, Intensity-Modulated
5
Docetaxel
4
Radiotherapy
3
Fluorouracil
3
Carboplatin
3
pembrolizumab
2
durvalumab
2
Radiation
2
Hydroxyurea
2
Drug Therapy
2
Celecoxib
2
Bupropion
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
gossypol acetic acid
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Platinum
1
Pilocarpine
1
Oral Hygiene
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Immunoglobulin G
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Laryngeal Neoplasms
×
tislelizumab
×
Clear all
No trials found.